| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 05/24/2000 | CN1253954A Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method |
| 05/24/2000 | CA2290213A1 Piperazinone derivatives |
| 05/23/2000 | US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
| 05/23/2000 | US6066736 Process for preparing alkoxypyrazine derivatives |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066650 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/23/2000 | US6066634 Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia |
| 05/23/2000 | CA2200959C 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives |
| 05/18/2000 | WO2000027795A1 Transfection reagents |
| 05/18/2000 | WO2000027792A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | WO2000027627A1 Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles |
| 05/18/2000 | WO2000008005A3 Piperazinone derivatives |
| 05/18/2000 | CA2348763A1 Novel compounds and medicinal use thereof |
| 05/17/2000 | EP1000999A1 Compounds for organic el devices and organic el devices |
| 05/17/2000 | EP1000619A2 Method for treating glaucoma |
| 05/17/2000 | EP1000617A2 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/17/2000 | EP1000047A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 05/17/2000 | EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | EP0999840A1 Use of draflazine-analogues for treating pain |
| 05/17/2000 | EP0973719A4 Method of preparing amino carboxylic acids |
| 05/17/2000 | EP0848701B1 O-benzyl oxime ether derivatives and their use in crop protection compositions |
| 05/17/2000 | EP0804191B1 Use of inhibitors of platelet derived growth receptor for the manufacture of a medicament for the treatment of cancers |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253551A Pyrazine compounds |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1253134A Process for preparing tetramethyl pyrazine |
| 05/16/2000 | US6063956 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides |
| 05/16/2000 | US6063784 Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 05/16/2000 | CA1340991C A-unsaturated amines, their production and use |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/10/2000 | EP0999256A1 Compounds for organic el element and organic el element |
| 05/10/2000 | EP0998465A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 05/10/2000 | EP0998464A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 05/10/2000 | EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 05/10/2000 | EP0685234B1 Drug composition containing nucleic acid copolymer |
| 05/10/2000 | CN1252799A N-heterocyclic derivatives as NOS inhibitor |
| 05/10/2000 | CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252402A Method for preparing HIV protease inhibitor |
| 05/09/2000 | US6060513 Compounds and compositions for delivering active agents |
| 05/09/2000 | CA1340990C Heterocyclic (alkyl) amines intermediates and their production |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/03/2000 | EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds |
| 05/03/2000 | EP0997153A1 Formulations for lipophilic compounds |
| 05/03/2000 | EP0996614A1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 05/03/2000 | EP0996439A1 $g(b)-ALKOXYACRYLATES AGAINST MALARIA |
| 05/03/2000 | CN1251836A Preparation of intermediate for monocyclic beta-lactams derivatives |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057323 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 05/02/2000 | US6057320 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| 05/02/2000 | US6057304 Treatment of central nervous system disorders |
| 05/02/2000 | US6057120 Quantitative or qualitative detection of analyte by contacting sample with indicator and detecting change in property of reagent; reagent is stable in reduced and oxidized forms |
| 04/27/2000 | WO2000023487A1 Amino-ketone solid support templates |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | CA2347243A1 Amino-ketone solid support templates |
| 04/26/2000 | EP0995742A1 Sulfonamide compounds and medicinal use thereof |
| 04/26/2000 | EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 04/26/2000 | EP0994834A1 Ligated platinum group metal catalyst complex and improved process for catalytically converting alkanes to esters and derivatives thereof |
| 04/25/2000 | US6054445 Kappa opioid agonist activity; analgesics and anti-pruritic agents |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021538A1 A method of modulating ion channel functional activity |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19949352A1 Heterocyclic alkoxyamine polymerization composition useful as regulator in free-radical polymerization to obtain low-polydispersity polymeric resins |
| 04/19/2000 | EP0994110A1 Sulphonamide derivatives |
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0993461A1 New quinoxaline dione derivatives, the production thereof and use of the same in medicaments |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993452A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/18/2000 | US6051669 Polymers from certain conjugated organic compounds |
| 04/18/2000 | US6051575 Piperazino derivatives as neurokinin antagonists |
| 04/18/2000 | US6051561 Compounds and compositions for delivering active agents |
| 04/16/2000 | CA2286375A1 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | CN1250444A 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
| 04/11/2000 | CA2082617C Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/04/2000 | US6046355 Dihydropyrones with improved antiviral activity |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017163A1 Cyanophenyl derivatives |
| 03/30/2000 | WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/29/2000 | EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents |
| 03/29/2000 | CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor |
| 03/28/2000 | US6043387 Chiral bisphosphines |
| 03/28/2000 | US6043250 Treating or preventing inflammatory diseases |
| 03/28/2000 | CA2180658C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2052063C Microbiological process for the production of hydroxylated heterocycles |
| 03/23/2000 | WO2000015634A2 Hiv protease inhibitors |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0986302A1 A method of treating cancer |